Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

ERN-EuroBloodNet European Collaborative Platform to Share COVID-19 Data in Patients With Red Blood Cell Disorders in Real Time

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06831799
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:50.807009+00:00
Published At
2025-02-18T00:00:00+00:00
Record Updated At
2025-02-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hemoglobinopathies", "Sickle Cell Disease", "Sickle Cell Anemia", "Sickle Beta Thalassemia", "Sickle-Cell; Hemoglobinopathy", "Sickle Cell Hemoglobin C", "Sickle Cell Hemoglobin D", "Sickle Cell-Hemoglobin E Disease", "Beta-Thalassemia", "Beta Thalassemia Major", "Beta Thalassemia Intermedia", "Dominant Beta-Thalassemia", "Hereditary Persistence of Fetal Hemoglobin Thalassemia", "Delta-Beta Thalassaemia", "Haemoglobin C-Beta-Thalassaemia Syndrome", "Hemoglobin E-Beta Thalassemia", "Alpha-Thalassemia", "Hemoglobin H Disease", "Hemoglobin Barts Hydrops", "Enzyme Disorder; Anemia", "Membranes; Disorder", "Elliptocytosis, Hereditary", "Stomatocytosis", "Spherocytosis, Hereditary"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-18"
protocolSection.identificationModule.nctId
"NCT06831799"
protocolSection.identificationModule.officialTitle
"ERN-EuroBloodNet European Collaborative Platform to Share COVID-19 Data in Patients With Red Blood Cell Disorders in Real Time"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hemoglobinopathies (protocolSection.conditionsModule.conditions)
  • Sickle Cell Disease (protocolSection.conditionsModule.conditions)
  • Sickle Cell Anemia (protocolSection.conditionsModule.conditions)
  • Sickle Beta Thalassemia (protocolSection.conditionsModule.conditions)
  • Sickle-Cell; Hemoglobinopathy (protocolSection.conditionsModule.conditions)
  • Sickle Cell Hemoglobin C (protocolSection.conditionsModule.conditions)
  • Sickle Cell Hemoglobin D (protocolSection.conditionsModule.conditions)
  • Sickle Cell-Hemoglobin E Disease (protocolSection.conditionsModule.conditions)
  • Beta-Thalassemia (protocolSection.conditionsModule.conditions)
  • Beta Thalassemia Major (protocolSection.conditionsModule.conditions)
  • Beta Thalassemia Intermedia (protocolSection.conditionsModule.conditions)
  • Dominant Beta-Thalassemia (protocolSection.conditionsModule.conditions)
  • Hereditary Persistence of Fetal Hemoglobin Thalassemia (protocolSection.conditionsModule.conditions)
  • Delta-Beta Thalassaemia (protocolSection.conditionsModule.conditions)
  • Haemoglobin C-Beta-Thalassaemia Syndrome (protocolSection.conditionsModule.conditions)
  • Hemoglobin E-Beta Thalassemia (protocolSection.conditionsModule.conditions)
  • Alpha-Thalassemia (protocolSection.conditionsModule.conditions)
  • Hemoglobin H Disease (protocolSection.conditionsModule.conditions)
  • Hemoglobin Barts Hydrops (protocolSection.conditionsModule.conditions)
  • Enzyme Disorder; Anemia (protocolSection.conditionsModule.conditions)
  • Membranes; Disorder (protocolSection.conditionsModule.conditions)
  • Elliptocytosis, Hereditary (protocolSection.conditionsModule.conditions)
  • Stomatocytosis (protocolSection.conditionsModule.conditions)
  • Spherocytosis, Hereditary (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.